Englewood Lab Balance Sheet Health
Financial Health criteria checks 5/6
Englewood Lab has a total shareholder equity of ₩126.6B and total debt of ₩24.7B, which brings its debt-to-equity ratio to 19.5%. Its total assets and total liabilities are ₩181.3B and ₩54.8B respectively. Englewood Lab's EBIT is ₩23.0B making its interest coverage ratio 75.4. It has cash and short-term investments of ₩30.4B.
Key information
19.5%
Debt to equity ratio
₩24.70b
Debt
| Interest coverage ratio | 75.4x |
| Cash | ₩30.40b |
| Equity | ₩126.56b |
| Total liabilities | ₩54.78b |
| Total assets | ₩181.34b |
Recent financial health updates
We Think Englewood Lab (KOSDAQ:950140) Can Manage Its Debt With Ease
Jun 20
These 4 Measures Indicate That Englewood Lab (KOSDAQ:950140) Is Using Debt Reasonably Well
Feb 05
Recent updates
Investors Will Want Englewood Lab's (KOSDAQ:950140) Growth In ROCE To Persist
Dec 03Englewood Lab, Inc. (KOSDAQ:950140) Might Not Be As Mispriced As It Looks After Plunging 30%
Nov 11Not Many Are Piling Into Englewood Lab, Inc. (KOSDAQ:950140) Stock Yet As It Plummets 30%
Nov 11Englewood Lab, Inc. (KOSDAQ:950140) Stocks Pounded By 28% But Not Lagging Market On Growth Or Pricing
Aug 07We Think Englewood Lab (KOSDAQ:950140) Can Manage Its Debt With Ease
Jun 20Is Now The Time To Put Englewood Lab (KOSDAQ:950140) On Your Watchlist?
May 24A Piece Of The Puzzle Missing From Englewood Lab, Inc.'s (KOSDAQ:950140) 25% Share Price Climb
May 09Investors Shouldn't Overlook Englewood Lab's (KOSDAQ:950140) Impressive Returns On Capital
May 08When Should You Buy Englewood Lab, Inc. (KOSDAQ:950140)?
Apr 16There Are Reasons To Feel Uneasy About Englewood Lab's (KOSDAQ:950140) Returns On Capital
Mar 31If You Had Bought Englewood Lab (KOSDAQ:950140) Shares A Year Ago You'd Have Earned 106% Returns
Mar 17What Kind Of Shareholders Hold The Majority In Englewood Lab, Inc.'s (KOSDAQ:950140) Shares?
Feb 23These 4 Measures Indicate That Englewood Lab (KOSDAQ:950140) Is Using Debt Reasonably Well
Feb 05Englewood Lab, Inc. (KOSDAQ:950140) Stock Is Going Strong But Fundamentals Look Uncertain: What Lies Ahead ?
Jan 20Is Englewood Lab, Inc. (KOSDAQ:950140) Potentially Undervalued?
Jan 02Returns On Capital At Englewood Lab (KOSDAQ:950140) Paint An Interesting Picture
Dec 15Are Englewood Lab's (KOSDAQ:950140) Statutory Earnings A Good Reflection Of Its Earnings Potential?
Nov 26Financial Position Analysis
Short Term Liabilities: A950140's short term assets (₩132.1B) exceed its short term liabilities (₩43.1B).
Long Term Liabilities: A950140's short term assets (₩132.1B) exceed its long term liabilities (₩11.7B).
Debt to Equity History and Analysis
Debt Level: A950140 has more cash than its total debt.
Reducing Debt: A950140's debt to equity ratio has reduced from 41% to 19.5% over the past 5 years.
Debt Coverage: A950140's debt is not well covered by operating cash flow (19.3%).
Interest Coverage: A950140's interest payments on its debt are well covered by EBIT (75.4x coverage).
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/26 19:28 |
| End of Day Share Price | 2024/12/26 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Englewood Lab, Inc. is covered by 4 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Kyung-rae Han | Daishin Securities Co. Ltd. |
| Sunhwa Lee | Eugene Investment & Securities Co Ltd. |
| Sang-Hun Lee | iM Securities |